April 6, 2014

CE Mark Approval of Vascutek's Anaconda AAA System Expanded for Use in Tortuous Anatomy

April 7, 2014—Vascutek (Inchinnan, United Kingdom) announced that European CE Mark approval for the Anaconda abdominal aortic aneurysm (AAA) stent graft system has been expanded to include treatment of infrarenal AAA in patients with proximal aortic neck angulation of ≤ 90º. This new indication provides a clinical solution for patients with tortuous anatomy.

According to the company, the Anaconda’s ring stent technology provides a proactive sealing system that conforms to the natural anatomy of the patient. Due to the flexibility of the device, it can be fully repositioned for accurate delivery to the target area, even in challenging anatomy. The Anaconda stent graft system was launched in 2005, the company noted.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

April 6, 2014

CE Mark Approval of Vascutek's Anaconda AAA System Expanded for Use in Tortuous Anatomy

Current Issue

Keep In Touch